Dyno Therapeutics Closes $100 Million Series A Financing Led By Andreessen Horowitz To Accelerate Ai‑Powered Gene Therapy Platform
Amount Raised
$100 Million
Round Type
Series A
Description
Dyno Therapeutics, Inc., a biotechnology company applying artificial intelligence (AI) to gene therapy, today announced a $100 million Series A financing led by Andreessen Horowitz, with participation from a select syndicate of new investors including Casdin Capital, GV, Obvious Ventures and Lux Capital. Founding investors Polaris Partners, CRV and KdT Ventures all participated in the round. Funds from this financing will directly fund expansion of the company’s CapsidMapTM platform, which uses AI technology for the design of novel Adeno-Associated Virus (AAV) gene therapy vectors, broadening the functionality and enhancing the therapeutic impact of gene therapies developed by Dyno’s biopharmaceutical partners.
Quick answer
Dyno Therapeutics raised $100 Million in a Series A round, dated May 6, 2021. Dyno Therapeutics is based in Cambridge, Massachusetts, United States.
- How much did Dyno Therapeutics raise?
- Dyno Therapeutics raised $100 Million in a Series A round on May 6, 2021.
- What does Dyno Therapeutics do?
- Dyno Therapeutics, Inc. is a genetic technologies company applying artificial intelligence (AI) to enable in vivo gene delivery.
- Where is Dyno Therapeutics based and how big is it?
- Dyno Therapeutics is based in Cambridge, Massachusetts, United States. Fundz records about 106 employees.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Dyno Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- PathAI raised an undisclosed amount (Funding Round) on May 18, 2021.
- Outcomes4Me raised $12M (Series A) on April 28, 2021.
- Outcomes4Me raised $12M on April 28, 2021.
- VieCure raised $25M (Series A) on April 20, 2021.
- pulseData, Inc. raised $17M on April 16, 2021.
- Health Plix raised $14M (Funding Round) on March 31, 2021.
Who to call at Dyno Therapeutics, and when
A new round usually means Dyno Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Dyno Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Dyno Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Dyno Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Dyno Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansDyno Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.